Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

(2011) M. T. Cibeira et al.   BLOOD

Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis

(2011) J. E. Ward et al.   BLOOD

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

(2011) D. E. Reece et al.   BLOOD

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue

(2011) F. Brambilla et al.   BLOOD

Clonal Plasma Cell Pathophysiology and Clinical Features of Disease Are Linked to Clonal Plasma Cell Expression of Cyclin D1 in Systemic Light-Chain Amyloidosis

(2011) Ping Zhou et al.   Clinical Lymphoma Myeloma & Leukemia

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis

(2011) A. D. Wechalekar et al.   HAEMATOLOGICA

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

(2010) Angela Dispenzieri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

(2010) A. V. Kristen et al.   BLOOD

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

(2010) G. Palladini et al.   BLOOD

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis

(2010) J. S. Wall et al.   BLOOD

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

(2010) S. Dietrich et al.   BLOOD

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Independent Predictors of Survival in Primary Systemic (AL) Amyloidosis, Including Cardiac Biomarkers and Left Ventricular Strain Imaging: An Observational Cohort Study

(2010) Diego Bellavia et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

(2010) Karl Bodin et al.   NATURE

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

(2009) D. E. Reece et al.   BLOOD

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

(2009) J. A. Vrana et al.   BLOOD

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis

(2009) A. H. Bryce et al.   HAEMATOLOGICA

Amyloidosis: is a cure possible?

(2008) G. Merlini et al.   ANNALS OF ONCOLOGY

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

(2008) T. Bochtler et al.   BLOOD

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

(2008) D. Lebovic et al.   BRITISH JOURNAL OF HAEMATOLOGY

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

(2008) A Dispenzieri et al.   LEUKEMIA

Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation

(2008) Ashutosh D Wechalekar et al.   Nature clinical practice. Cardiovascular medicine